The Disease-Modifying Effects of Hyaluronan in the Osteoarthritic Disease State

por Nicholls, Mathew A, Fierlinger, Anke, Niazi, Faizan, Bhandari, Mohit
Publicado 2017

Clinicians’ Perspectives on the Use of Intra-Articular Hyaluronic Acid as a Treatment for Knee Osteoarthritis: A North American, Multidisciplinary Survey

por Rosen, Jeffrey, Avram, Victoria, Fierlinger, Anke, Niazi, Faizan, Sancheti, Parag, Bedi, Asheesh
Publicado 2016

Cost-Effectiveness of Different Forms of Intra-Articular Injections for the Treatment of Osteoarthritis of the Knee

por Rosen, Jeffrey, Sancheti, Parag, Fierlinger, Anke, Niazi, Faizan, Johal, Herman, Bedi, Asheesh
Publicado 2016

Potential Impact of Biologically Derived Hyaluronic Acid on Quality of Life in Patients with Knee Osteoarthritis in the United States

por Rosen, Jeffrey, Sancheti, Parag, Fierlinger, Anke, Niazi, Faizan, Johal, Herman, Bedi, Asheesh
Publicado 2016

Response to: Important Considerations When Determining the Cost-effectiveness of Viscosupplements in the Treatment of Knee Osteoarthritis

por Rosen, Jeffrey, Sancheti, Parag, Fierlinger, Anke, Niazi, Faizan, Johal, Herman, Bedi, Asheesh
Publicado 2016

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

por Baraliakos, Xenofon, Braun, Juergen, Deodhar, Atul, Poddubnyy, Denis, Kivitz, Alan, Tahir, Hasan, Van den Bosch, Filip, Delicha, Evie-Maria, Talloczy, Zsolt, Fierlinger, Anke
Publicado 2019